Price $567.75 |
Market Cap
262.22B
|
Sector Health Care |
Div. Growth
17.10%
|
|
P/E
31.0
|
P/B
6.79
|
P/S
6.73
|
Dividend %
0.20%
|
|
P/CF
59.3
|
P/FCF
35.2
|
Op. Cash Flow
10.19M
|
FCF
18.9
|
|
Op. Margin
27.00%
|
Net Margin
21.90%
|
ROE
23.60%
|
ROI
12.30%
|
|
ROA
12.40%
|
EPS Growth
76.60%
|
Current Ratio
2.1
|
Debt/Equity
55.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| PetIQ Inc (PETQ) | $20.40 | - | - | 669.1M | Strong Buy |
| Lannett Company, Inc. (LCI) | $1.52 | - | - | 71.5M | Strong Buy |
| Recro Pharma Inc (REPH) | $1.56 | - | - | 68.5M | Strong Buy |
| Akumin Inc (AKU) | $1.49 | - | - | 184.9M | Strong Buy |
| Emmaus Life Sciences Inc (EMMA) | $1.46 | - | - | 75M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
